Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,354 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Slow-Cycling Cancer Stem Cells Regulate Progression and Chemoresistance in Colon Cancer.
Shiokawa D, Sakai H, Ohata H, Miyazaki T, Kanda Y, Sekine S, Narushima D, Hosokawa M, Kato M, Suzuki Y, Takeyama H, Kambara H, Nakagama H, Okamoto K. Shiokawa D, et al. Among authors: kanda y. Cancer Res. 2020 Oct 15;80(20):4451-4464. doi: 10.1158/0008-5472.CAN-20-0378. Epub 2020 Aug 19. Cancer Res. 2020. PMID: 32816913
Integrative analyses of gene expression and chemosensitivity of patient-derived ovarian cancer spheroids link G6PD-driven redox metabolism to cisplatin chemoresistance.
Yamawaki K, Mori Y, Sakai H, Kanda Y, Shiokawa D, Ueda H, Ishiguro T, Yoshihara K, Nagasaka K, Onda T, Kato T, Kondo T, Enomoto T, Okamoto K. Yamawaki K, et al. Among authors: kanda y. Cancer Lett. 2021 Aug 19;521:29-38. doi: 10.1016/j.canlet.2021.08.018. Online ahead of print. Cancer Lett. 2021. PMID: 34419499 Free article.
Targeting PDGF signaling of cancer-associated fibroblasts blocks feedback activation of HIF-1α and tumor progression of clear cell ovarian cancer.
Mori Y, Okimoto Y, Sakai H, Kanda Y, Ohata H, Shiokawa D, Suzuki M, Yoshida H, Ueda H, Sekizuka T, Tamura R, Yamawaki K, Ishiguro T, Mateos RN, Shiraishi Y, Yatabe Y, Hamada A, Yoshihara K, Enomoto T, Okamoto K. Mori Y, et al. Among authors: kanda y. Cell Rep Med. 2024 Apr 23:101532. doi: 10.1016/j.xcrm.2024.101532. Online ahead of print. Cell Rep Med. 2024. PMID: 38670097 Free article.
Loss of the cystine/glutamate antiporter in melanoma abrogates tumor metastasis and markedly increases survival rates of mice.
Sato M, Onuma K, Domon M, Hasegawa S, Suzuki A, Kusumi R, Hino R, Kakihara N, Kanda Y, Osaki M, Hamada J, Bannai S, Feederle R, Buday K, Angeli JPF, Proneth B, Conrad M, Okada F, Sato H. Sato M, et al. Among authors: kanda y. Int J Cancer. 2020 Dec 1;147(11):3224-3235. doi: 10.1002/ijc.33262. Epub 2020 Aug 26. Int J Cancer. 2020. PMID: 32818320 Free article.
1,354 results